tradmap

TDOC Teladoc Health, Inc.

$8.64 +1.41%

Data as of close

Healthcare · Services-Offices & Clinics Of Doctors Of Medicine

Teladoc Health, Inc. (TDOC) is a healthcare company in the Services-Offices & Clinics Of Doctors Of Medicine industry, with a market capitalization of $1.6 billion. Shares last traded at $8.64, 12.6% below their 52-week high. Over the past year the stock is down 1.2%. Net profit margin is -6.3%, below the peer median of -6.2%. Revenue declined 1.5% year over year.

Market Cap
$1.6B
Shares Out
182.3M
EPS (TTM)
-$0.86
P/E (TTM)*
—
P/S Ratio
0.64
P/B Ratio
1.22
Dividend / Share
—
Dividend Yield
—
52-Week High
$9.88
52-Week Low
$4.40
Volume (venue)
422,488
Avg Vol (3m, venue)
247,821.937

* P/E (TTM) = market cap ÷ net income over the trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year — the same basis as the peer table and the screener, so it can differ from price ÷ EPS.

Performance

1W
+38.35%
1M
+56.81%
3M
+28.76%
6M
+30.32%
YTD
+23.61%
1Y
-1.20%

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)
78.38
SMA (50)
$6.29
SMA (200)
$6.47
Price vs SMA50
+37.38%
Price vs SMA200
+33.50%
ATR (14)
$0.47

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue
$2.5B
Net Income
-$155M
Gross Margin
11.7%
Operating Margin
-6.6%
Net Margin
-6.3%
Return on Equity
-12.0%
Return on Assets
-5.6%
Current Ratio
0.87
Debt / Equity
0.03
Revenue Growth (YoY)
-1.5%

Trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year; revenue is the fiscal-year figure where quarterly revenue covers under half of it (typical for banks, insurers and REITs), and margins are taken on it; latest reported period ends 2026-09-30. Source: SEC EDGAR/XBRL.

Full financials — revenue, cash flow & debt over time →

Recent earnings

PeriodEPS (diluted)Reported
Q3 2026 -$0.15 2026-10-29
Q2 2026 -$0.21 2026-07-30
Q1 2026 -$0.36 2026-04-30
Q4 2025 (derived) -$0.14 2026-02-26
FY 2025 -$1.14 2026-02-26
Q3 2025 -$0.28 2025-10-30

Q4 marked "derived" = fiscal-year EPS minus Q1–Q3 (10-Ks report only the annual figure); EPS is not strictly additive, so it can differ by a cent or two from the issuer's own Q4.

Full earnings history →

Services-Offices & Clinics Of Doctors Of Medicine peers

TDOC vs 11 industry peers (Services-Offices & Clinics Of Doctors Of Medicine), by market cap. Data as of close

P/S vs peers
0.64 / 0.94 med
-32% discount
Net margin vs peers
-6.3% / -6.2% med
below median
1–11 of 11
HIMSHims & Hers Health, Inc.$5.9B—2.28-5.5%-8.85%
TDOCTeladoc Health, Inc.$1.6B—0.64-6.3%+1.41%
STLNStarling Oncology, Inc.$637M—1.08-6.2%-4.21%
SBCSBC Medical Group Holdings Inc$546M11.143.1228.0%+0.66%
AIRSAirsculpt Technologies, Inc.$120M—0.80-7.8%-5.11%
LFMDLifemd, Inc.$111M551.520.670.1%+0.00%
WSTNWestin Acquisition Corp$81M91.04——+0.00%
BMGLBasel Medical Group Ltd$8M———+1.48%
CCMConcord Medical Services Holdings Ltd———-20.2%+4.94%
AUNAAuna S.A.————-0.22%
SBCWWSBC Medical Group Holdings Inc————+31.31%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.